RESEARCH USE ONLY. ≥98% HPLC PURITY. SAME-DAY ORDER DISPATCH. TEMPERATURE-CONTROLLED STORAGE. FREE UK SHIPPING ON ORDERS £49.99+
Lynx Peptides

Animal & cell studies

BPC-157

Tendon-cell movement, vascular receptor signalling and gastrointestinal injury models give BPC-157 a predominantly preclinical tissue-biology literature.

Research summary

BPC-157 is a peptide of 15 amino-acid residues. Its tendon-cell literature distinguishes migration, the movement of cells, from proliferation, an increase in cell number. In rat-derived tendon fibroblasts, migration and survival under oxidative stress changed without a direct increase in ordinary proliferation. PMID 21030672

VEGFR2 is vascular endothelial growth factor receptor 2. Receptor trafficking describes its movement between the cell surface and intracellular compartments. The endothelial study linked BPC-157 with VEGFR2 internalisation and downstream signalling without increased VEGF-A expression. This is a mechanistic observation, distinct from a controlled human outcome or evidence of an additive effect with TB-500. PMID 27847966

BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.

Current pharmaceutical design 2018

Seiwerth S, Rucman R, Turkovic B, Sever M, Klicek R, Radic B, Drmic D, Stupnisek M, Misic M, Vuletic LB, Pavlov KH, Barisic I, Kokot A, Japjec M, Blagaic AB, Tvrdeic A, Rokotov DS, Vrcic H, Staresinic M, Sebecic B, Sikiric P

Review of animal and in-vitro studies

Gastrointestinal injury models place BPC-157 in a broader discussion of mucosal repair and vascular growth signals. A narrative review also brings together tendon, ligament, muscle and bone observations, comparing them with EGF, FGF and VEGF research. Its breadth helps organise the preclinical literature, but it is not a controlled human result or a systematic estimate of benefit.

View on PubMed

Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth.

Journal of orthopaedic research 2003

Staresinic M, Sebecic B, Patrlj L, Jadrijevic S, Suknaic S, Perovic D, Aralica G, Zarkovic N, Borovic S, Srdjak M, Hajdarevic K, Kopljar M, Batelja L, Boban-Blagaic A, Turcic I, Anic T, Seiwerth S, Sikiric P

Rat tendon and ligament injury models

BPC-157-treated rats had stronger functional and biomechanical measurements after Achilles tendon transection, together with more organised repair tissue than saline controls. In related cell experiments, BPC-157 opposed growth inhibition caused by the reactive aldehyde 4-hydroxynonenal. The tissue and cell results address different parts of an acute repair response and remain preclinical observations.

View on PubMed

Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing.

Journal of physiology and pharmacology 2009

Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S

Rat and cellular injury models

BPC-157 did not produce a direct angiogenic response in the cell cultures used in one experiment, while rat muscle and tendon injury models showed altered VEGF expression and vascular markers. The difference suggests that the injury environment can shape the measured response. It also cautions against treating all angiogenesis assays as interchangeable.

View on PubMed

The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.

Journal of applied physiology (Bethesda, Md. 2011

Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH

Cellular and animal mechanistic research

BPC-157 increased tendon-fibroblast migration, spreading and survival under oxidative stress without directly increasing ordinary cell proliferation. FAK and paxillin phosphorylation rose, while total amounts of those proteins did not. The result connects cell movement with focal-adhesion signalling in rat-derived tendon cells.

View on PubMed

Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.

Journal of molecular medicine (Berlin, Germany) 2017

Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, Ko YS, Wang JS, Chang VH, Pang JS

Cellular and animal mechanistic research

BPC-157 increased VEGFR2 expression and internalisation in endothelial cells, with activation of the VEGFR2–Akt–eNOS pathway. Tube formation and animal vascular measurements also changed, while VEGF-A expression in the cell experiments did not increase. Blocking endocytosis suppressed several responses, linking receptor trafficking with the observed angiogenic signal.

View on PubMed

Models studied

  • Gastrointestinal experimental models
  • Tendon and ligament injury models
  • Muscle and tissue-repair models
  • Angiogenesis-related signalling

Key findings

  • Tendon-cell movement and attachment

    Cell movement and stress survival changed without a direct rise in ordinary proliferation; focal-adhesion phosphorylation helps distinguish those responses.

  • Vascular receptor trafficking

    VEGFR2 trafficking and downstream signalling changed without increased VEGF-A expression, locating the response beyond simple growth-factor production.

  • Gastrointestinal model context

    The gastrointestinal research sits within a wider preclinical tissue literature; the review organises that evidence rather than supplying a controlled human outcome.

  • Why angiogenesis assays differ

    A cell-culture null result alongside vascular changes in injured rat tissues illustrates the importance of the experimental environment.

References

  1. BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.

    Current pharmaceutical design 2018

    Seiwerth S, Rucman R, Turkovic B, Sever M, Klicek R, Radic B, Drmic D, Stupnisek M, Misic M, Vuletic LB, Pavlov KH, Barisic I, Kokot A, Japjec M, Blagaic AB, Tvrdeic A, Rokotov DS, Vrcic H, Staresinic M, Sebecic B, Sikiric P

    PMID 29998800

    View on PubMed

  2. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth.

    Journal of orthopaedic research 2003

    Staresinic M, Sebecic B, Patrlj L, Jadrijevic S, Suknaic S, Perovic D, Aralica G, Zarkovic N, Borovic S, Srdjak M, Hajdarevic K, Kopljar M, Batelja L, Boban-Blagaic A, Turcic I, Anic T, Seiwerth S, Sikiric P

    PMID 14554208

    View on PubMed

  3. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing.

    Journal of physiology and pharmacology 2009

    Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S

    PMID 20388964

    View on PubMed

  4. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.

    Journal of applied physiology (Bethesda, Md. 2011

    Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH

    PMID 21030672

    View on PubMed

  5. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.

    Journal of molecular medicine (Berlin, Germany) 2017

    Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, Ko YS, Wang JS, Chang VH, Pang JS

    PMID 27847966

    View on PubMed

For laboratory research use only. Content is provided for research reference and is not intended as medical or veterinary guidance.